Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-20-059976
Filing Date
2020-11-23
Accepted
2020-11-23 16:34:14
Documents
1
Period of Report
2020-11-23

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 10957
  Complete submission text file 0001209191-20-059976.txt   12341
Mailing Address 512 2ND STREET, 4TH FLOOR SAN FRANCISCO CA 94107
Business Address 512 2ND STREET, 4TH FLOOR SAN FRANCISCO CA 94107 (415) 651-3316
Olema Pharmaceuticals, Inc. (Issuer) CIK: 0001750284 (see all company filings)

EIN.: 300409740 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O OLEMA PHARMACEUTICALS, INC. 512 2ND STREET, 4TH FLOOR SAN FRANCISCO CA 94107
Business Address
Myles David C. (Reporting) CIK: 0001831216 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39712 | Film No.: 201338068